CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer’s Disease (AD)

Neurodegenerative Disorder
Alzheimer's Disease (AD)

Results
Download
Print

Study results

LPS BN29552 CREAD Final Results March 2022 English (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Bulgarian (PDF, 2.3 MB)

LPS BN29552 CREAD Final Results March 2022 Chinese Simplified PRC (PDF, 0.9 MB)

LPS BN29552 CREAD Final Results March 2022 Chinese Traditional Hong Kong (PDF, 1.0 MB)

LPS BN29552 CREAD Final Results March 2022 Croatian (PDF, 0.6 MB)

LPS BN29552 CREAD Final Results March 2022 Danish (PDF, 0.6 MB)

LPS BN29552 CREAD Final Results March 2022 Dutch Netherlands (PDF, 2.6 MB)

LPS BN29552 CREAD Final Results March 2022 Finnish (PDF, 2.3 MB)

LPS BN29552 CREAD Final Results March 2022 French France (PDF, 2.6 MB)

LPS BN29552 CREAD Final Results March 2022 German Germany (PDF, 2.6 MB)

LPS BN29552 CREAD Final Results March 2022 Hungarian (PDF, 2.6 MB)

LPS BN29552 CREAD Final Results March 2022 Italian Italy (PDF, 2.3 MB)

LPS BN29552 CREAD Final Results March 2022 Japanese (PDF, 0.8 MB)

LPS BN29552 CREAD Final Results March 2022 Korean (PDF, 1.0 MB)

LPS BN29552 CREAD Final Results March 2022 Lithuanian (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Polish (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Portuguese Portugal (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Russian Russia (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Slovenian (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Spanish Mexico (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Spanish Spain (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Swedish (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Turkish (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Ukrainian (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results April 2022 Czech (PDF, 0.6 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

For the latest version of this information please go to www.forpatients.roche.com

CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer’s Disease (AD)

Study results

LPS BN29552 CREAD Final Results March 2022 English (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Bulgarian (PDF, 2.3 MB)

LPS BN29552 CREAD Final Results March 2022 Chinese Simplified PRC (PDF, 0.9 MB)

LPS BN29552 CREAD Final Results March 2022 Chinese Traditional Hong Kong (PDF, 1.0 MB)

LPS BN29552 CREAD Final Results March 2022 Croatian (PDF, 0.6 MB)

LPS BN29552 CREAD Final Results March 2022 Danish (PDF, 0.6 MB)

LPS BN29552 CREAD Final Results March 2022 Dutch Netherlands (PDF, 2.6 MB)

LPS BN29552 CREAD Final Results March 2022 Finnish (PDF, 2.3 MB)

LPS BN29552 CREAD Final Results March 2022 French France (PDF, 2.6 MB)

LPS BN29552 CREAD Final Results March 2022 German Germany (PDF, 2.6 MB)

LPS BN29552 CREAD Final Results March 2022 Hungarian (PDF, 2.6 MB)

LPS BN29552 CREAD Final Results March 2022 Italian Italy (PDF, 2.3 MB)

LPS BN29552 CREAD Final Results March 2022 Japanese (PDF, 0.8 MB)

LPS BN29552 CREAD Final Results March 2022 Korean (PDF, 1.0 MB)

LPS BN29552 CREAD Final Results March 2022 Lithuanian (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Polish (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Portuguese Portugal (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Russian Russia (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Slovenian (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Spanish Mexico (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Spanish Spain (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Swedish (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Turkish (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results March 2022 Ukrainian (PDF, 0.4 MB)

LPS BN29552 CREAD Final Results April 2022 Czech (PDF, 0.6 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer’s Disease (AD)

For the latest version of this information please go to www.forpatients.roche.com